Myelography with metrizamide.
Metrizamide (Amipaque) is a new water-soluble contrast medium for myelography. It differs from the conventional contrast media in that, because of its lower toxicity, it can be used also for cervical and thoracic myelography. The method of examination in myelography with water-soluble contrast media differs in some respects from that in myelography with oil-soluble contrast media. For the thoracic region, tomography is highly recommendable. After a description of the method of examination used, some examples of the abnormalities found are presented.
D000328:Adult; D001165:Arteriovenous Malformations / Q000000981:diagnostic imaging; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007463:Iodobenzoates; D008297:Male; D008793:Metrizamide / Q000009:adverse effects; D008875:Middle Aged; D009192:Myelography / Q000379:methods; D009456:Neurofibromatosis 1 / Q000000981:diagnostic imaging; D012995:Solubility; D013118:Spinal Cord Diseases / Q000000981:diagnostic imaging; D014056:Tomography, X-Ray
D007463:Iodobenzoates; D008793:Metrizamide